Literature DB >> 12719257

Molecular dynamics simulations on the first two helices of Vpu from HIV-1.

I Sramala1, V Lemaitre, J D Faraldo-Gómez, S Vincent, A Watts, W B Fischer.   

Abstract

Vpu is an 81 amino acid protein of HIV-1 with two phosphorylation sites. It consists of a short N-terminal end traversing the bilayer and a longer cytoplasmic part. The dual functional role of Vpu is attributed to these topological distinct regions of the protein. The first 52 amino acids of Vpu (HV1H2) have been simulated, which are thought to be embedded in a fully hydrated lipid bilayer and to consist of a transmembrane helix (helix-1) connected via a flexible linker region, including a Glu-Tyr-Arg (EYR) motif, with a second helix (helix-2) residing with its helix long axis on the bilayer surface. Repeated molecular dynamics simulations show that Glu-28 is involved in salt bridge formation with Lys-31 and Arg-34 establishing a kink between the two helices. Helix-2 remains in a helical conformation indicating its stability and function as a "peptide float," separating helix-1 from the rest of the protein. This leads to the conclusion that Vpu consists of three functional modules: helix-1, helix-2, and the remaining residues toward the C-terminal end.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719257      PMCID: PMC1302888          DOI: 10.1016/S0006-3495(03)70052-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  56 in total

1.  Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution.

Authors:  J Deisenhofer; O Epp; K Miki; R Huber; H Michel
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

Review 2.  The multiplicity of domains in proteins.

Authors:  R F Doolittle
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  FT-IR spectroscopy of the major coat protein of M13 and Pf1 in the phage and reconstituted into phospholipid systems.

Authors:  W F Wolkers; P I Haris; A M Pistorius; D Chapman; M A Hemminga
Journal:  Biochemistry       Date:  1995-06-20       Impact factor: 3.162

4.  Are buried salt bridges important for protein stability and conformational specificity?

Authors:  C D Waldburger; J F Schildbach; R T Sauer
Journal:  Nat Struct Biol       Date:  1995-02

5.  Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy.

Authors:  V Wray; T Federau; P Henklein; S Klabunde; O Kunert; D Schomburg; U Schubert
Journal:  Int J Pept Protein Res       Date:  1995-01

6.  The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.

Authors:  S Bour; U Schubert; K Strebel
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Evaluation of transmembrane helix prediction methods using the recently defined NMR structures of the coat proteins from bacteriophages M13 and Pf1.

Authors:  R J Turner; J H Weiner
Journal:  Biochim Biophys Acta       Date:  1993-09-03

8.  Do salt bridges stabilize proteins? A continuum electrostatic analysis.

Authors:  Z S Hendsch; B Tidor
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

9.  Complex salt bridges in proteins: statistical analysis of structure and function.

Authors:  B Musafia; V Buchner; D Arad
Journal:  J Mol Biol       Date:  1995-12-08       Impact factor: 5.469

10.  Parallel helix bundles and ion channels: molecular modeling via simulated annealing and restrained molecular dynamics.

Authors:  I D Kerr; R Sankararamakrishnan; O S Smart; M S Sansom
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

View more
  9 in total

1.  Structural implications of mutations assessed by molecular dynamics: Vpu1-32 from HIV-1.

Authors:  J Krüger; Wolfgang B Fischer
Journal:  Eur Biophys J       Date:  2009-06-09       Impact factor: 1.733

2.  Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release.

Authors:  Autumn Ruiz; M Sarah Hill; Kimberly Schmitt; Edward B Stephens
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

3.  Structural determination of virus protein U from HIV-1 by NMR in membrane environments.

Authors:  Hua Zhang; Eugene C Lin; Bibhuti B Das; Ye Tian; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2015-09-08

4.  Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization.

Authors:  Chin-Pei Chen; Meng-Han Lin; Ya-Ting Chan; Li-Chyong Chen; Che Ma; Wolfgang B Fischer
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

5.  Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism.

Authors:  Sabelo Lukhele; Éric A Cohen
Journal:  Retrovirology       Date:  2017-03-14       Impact factor: 4.602

Review 6.  Mechanism of function of viral channel proteins and implications for drug development.

Authors:  Wolfgang B Fischer; Yi-Ting Wang; Christina Schindler; Chin-Pei Chen
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

7.  Rotational Dynamics of The Transmembrane Domains Play an Important Role in Peptide Dynamics of Viral Fusion and Ion Channel Forming Proteins-A Molecular Dynamics Simulation Study.

Authors:  Chia-Wen Wang; Wolfgang B Fischer
Journal:  Viruses       Date:  2022-03-28       Impact factor: 5.818

8.  In silico analysis reveals sequential interactions and protein conformational changes during the binding of chemokine CXCL-8 to its receptor CXCR1.

Authors:  Je-Wen Liou; Fang-Tzu Chang; Yi Chung; Wen-Yi Chen; Wolfgang B Fischer; Hao-Jen Hsu
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

Review 9.  Viral channel forming proteins--How to assemble and depolarize lipid membranes in silico.

Authors:  Wolfgang B Fischer; Monoj Mon Kalita; Dieter Heermann
Journal:  Biochim Biophys Acta       Date:  2016-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.